GNPX

Conviction 49HealthcareScan · Tue, Sep 8, 2026

GNPX$3.51+0.29%

ResistanceSupportVol 14Insider sellCongress buyCongress sell

Vol MA14 76.19K

Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8

Genprex, Inc.PHARMACEUTICAL PREPARATIONSwww.genprex.com ↗

Price3.51

Change+0.29%

Gap-2.29%

Rel volume0.22×

Avg volume311.62K

Avg $ vol1.25M

SMA 203.96

SMA 504.03

SMA 2002.32

Price vs 50-13.00%

Price vs 200+51.45%

MA stackmixed

50/200 cross—

Supertrenddown · 4.55

RSI (14)41

MACD hist-0.08

MACD cross—

Stoch %K / %D15 / 9

ADX (14)13

+DI / −DI20 / 26

RSI divergence—

MACD divergence—

ATR %+11.56%

ADR %9.14%

52w high11.50

52w low0.1673

From 52w high-69.48%

Above 52w low+1998.03%

New 52w highNo

SqueezeOff

Bollinger width41.80%

%B0.23

Donchian pos7.50%

Donchian high5.24

Donchian low3.37

AVWAP (52w high)2.74

vs AVWAP high+28.16%

AVWAP (52w low)0.9323

vs AVWAP low+276.49%

OBV trendDown

Chaikin MF (20)-0.59

Today vs 20d0.22×

Avg vol (14d)76.19K

Avg vol (20d)311.62K

Avg $ vol (20d)1.25M

Market cap2.88M

RS 3m (vs SPY)+436.78%

RS 6m (vs SPY)+64.94%

RS line new highNo

Trend template3/8

Technical rank62.4

1 week-5.39%

1 month-17.80%

3 months+423.10%

6 months+77.27%

1 year+1429.41%

YTD+96.09%

P/E-0.18

P/B0.19

P/S—

P/FCF-0.19

EPS-0.4200

Div yield—

ROE-109.69%

ROA-94.70%

Debt/Eq—

Current6.77

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth23.13%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-12.28M

Revenue0

Net income-4.45M

Gross profit—

Free cash flow-15.31M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out10.93M

Employees13

ListedThu, Mar 29, 2018

Free float40.4M

Float %94.2%

Short interest62.59K

Days to cover0.2d

Short volume31.6%

Squeeze score1 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction49 / 100

Pattern quality—

Tech rank62.4 / 100

Group rank96 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance9.25

Support3.47

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in GNPX · 1 recent

All disclosures →

Member	Side	Amount	Traded	Filed	PTR
Tim Moore house · NC · traded 2025-12-18	Buy	$1K–$15K	2025-12-18	2026-01-03	PDF

Insider activity

SEC Form 4 transactions in GNPX · 2 sells

Insider	Side	Shares	Value	Traded	Filed
LONGNECKER BRENT M Director · Common Stock · 2026-04-14	Sell	10	$12	2026-04-14	2026-04-15
LONGNECKER BRENT M Director · Common Stock · 2026-04-14	Sell	8	$10	2026-04-14	2026-04-15

SEC filings

EDGAR filings in GNPX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.

GNPX

Recent news

Get daily signals & real-time alerts.